Related Experiment Videos
Mutations in TITF-1 are associated with benign hereditary chorea
Guido J Breedveld1, Jeroen W F van Dongen, Cesare Danesino
1Department of Clinical Genetics, Erasmus University, Rotterdam, The Netherlands.
Human Molecular Genetics
|April 25, 2002
Summary
Benign hereditary chorea (BHC) is a rare movement disorder. Genetic analysis reveals that mutations in the TITF-1 gene are associated with this non-progressive condition.
Area of Science:
- Genetics
- Neurology
- Developmental Biology
Background:
- Benign hereditary chorea (BHC) is an autosomal dominant movement disorder with early onset.
- Symptoms include dysarthria, axial dystonia, and gait disturbances, with variable severity.
- BHC is non-progressive and distinct from Huntington disease, suggesting a developmental brain disturbance.
Purpose of the Study:
- To identify the genetic cause of Benign hereditary chorea.
- To investigate the role of the TITF-1 gene in BHC pathogenesis.
Main Methods:
- Genetic linkage analysis in BHC families to identify a chromosomal locus.
- Fine-mapping of the critical region on chromosome 14.
- Analysis of a de novo deletion in a BHC family to identify candidate genes.
Main Results:
- A locus for BHC was previously identified on chromosome 14.
- Recombination analysis narrowed the critical interval to 8.4 cM.
- A de novo deletion encompassing the TITF-1 gene was found in a BHC family.
Conclusions:
- Mutations in the TITF-1 gene are associated with Benign hereditary chorea.
- TITF-1, a transcription factor crucial for basal ganglia development, is implicated in BHC.
- This finding provides insight into the genetic basis of early-onset movement disorders.